Pneumococcal meningitis in a patient with severe COVID-19 on dexamethasone and tocilizumab: A case report

Although various therapeutic agents have been tried for coronavirus disease-2019 (COVID-19) and evidence has accumulated, the risk of secondary infection is increased by underlying disease and immunosuppressive drugs. We report a case of pneumococcal meningitis in a patient with severe COVID-19 who...

Descripción completa

Detalles Bibliográficos
Autores principales: Murayama, Yoshiaki, Ishimine, Tomohiko, Sasano, Mikio, Todaka, Takafumi, Matsumoto, Takashi, Shimabukuro, Taiga, Yonaha, Risa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981263/
https://www.ncbi.nlm.nih.gov/pubmed/36896031
http://dx.doi.org/10.1016/j.idcr.2023.e01727
_version_ 1784900064392511488
author Murayama, Yoshiaki
Ishimine, Tomohiko
Sasano, Mikio
Todaka, Takafumi
Matsumoto, Takashi
Shimabukuro, Taiga
Yonaha, Risa
author_facet Murayama, Yoshiaki
Ishimine, Tomohiko
Sasano, Mikio
Todaka, Takafumi
Matsumoto, Takashi
Shimabukuro, Taiga
Yonaha, Risa
author_sort Murayama, Yoshiaki
collection PubMed
description Although various therapeutic agents have been tried for coronavirus disease-2019 (COVID-19) and evidence has accumulated, the risk of secondary infection is increased by underlying disease and immunosuppressive drugs. We report a case of pneumococcal meningitis in a patient with severe COVID-19 who was receiving dexamethasone and tocilizumab. The patient's symptoms improved with appropriate diagnosis and antimicrobial therapy, and she fortunately returned to society without any neurological sequelae of meningitis.
format Online
Article
Text
id pubmed-9981263
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-99812632023-03-03 Pneumococcal meningitis in a patient with severe COVID-19 on dexamethasone and tocilizumab: A case report Murayama, Yoshiaki Ishimine, Tomohiko Sasano, Mikio Todaka, Takafumi Matsumoto, Takashi Shimabukuro, Taiga Yonaha, Risa IDCases Case Report Although various therapeutic agents have been tried for coronavirus disease-2019 (COVID-19) and evidence has accumulated, the risk of secondary infection is increased by underlying disease and immunosuppressive drugs. We report a case of pneumococcal meningitis in a patient with severe COVID-19 who was receiving dexamethasone and tocilizumab. The patient's symptoms improved with appropriate diagnosis and antimicrobial therapy, and she fortunately returned to society without any neurological sequelae of meningitis. Elsevier 2023-03-03 /pmc/articles/PMC9981263/ /pubmed/36896031 http://dx.doi.org/10.1016/j.idcr.2023.e01727 Text en © 2023 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Murayama, Yoshiaki
Ishimine, Tomohiko
Sasano, Mikio
Todaka, Takafumi
Matsumoto, Takashi
Shimabukuro, Taiga
Yonaha, Risa
Pneumococcal meningitis in a patient with severe COVID-19 on dexamethasone and tocilizumab: A case report
title Pneumococcal meningitis in a patient with severe COVID-19 on dexamethasone and tocilizumab: A case report
title_full Pneumococcal meningitis in a patient with severe COVID-19 on dexamethasone and tocilizumab: A case report
title_fullStr Pneumococcal meningitis in a patient with severe COVID-19 on dexamethasone and tocilizumab: A case report
title_full_unstemmed Pneumococcal meningitis in a patient with severe COVID-19 on dexamethasone and tocilizumab: A case report
title_short Pneumococcal meningitis in a patient with severe COVID-19 on dexamethasone and tocilizumab: A case report
title_sort pneumococcal meningitis in a patient with severe covid-19 on dexamethasone and tocilizumab: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981263/
https://www.ncbi.nlm.nih.gov/pubmed/36896031
http://dx.doi.org/10.1016/j.idcr.2023.e01727
work_keys_str_mv AT murayamayoshiaki pneumococcalmeningitisinapatientwithseverecovid19ondexamethasoneandtocilizumabacasereport
AT ishiminetomohiko pneumococcalmeningitisinapatientwithseverecovid19ondexamethasoneandtocilizumabacasereport
AT sasanomikio pneumococcalmeningitisinapatientwithseverecovid19ondexamethasoneandtocilizumabacasereport
AT todakatakafumi pneumococcalmeningitisinapatientwithseverecovid19ondexamethasoneandtocilizumabacasereport
AT matsumototakashi pneumococcalmeningitisinapatientwithseverecovid19ondexamethasoneandtocilizumabacasereport
AT shimabukurotaiga pneumococcalmeningitisinapatientwithseverecovid19ondexamethasoneandtocilizumabacasereport
AT yonaharisa pneumococcalmeningitisinapatientwithseverecovid19ondexamethasoneandtocilizumabacasereport

Ejemplares similares